{"id":766713,"date":"2026-05-01T21:12:22","date_gmt":"2026-05-01T21:12:22","guid":{"rendered":"https:\/\/www.europesays.com\/us\/766713\/"},"modified":"2026-05-01T21:12:22","modified_gmt":"2026-05-01T21:12:22","slug":"canada-approves-second-generic-version-of-ozempic","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/766713\/","title":{"rendered":"Canada approves second generic version of Ozempic"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\">OTTAWA, May 1 (Reuters) &#8211; The \u200cCanadian \u200chealth regulator said \u200bon Friday that it had \u200capproved Canada-based \u2060Apotex&#8217;s generic version \u2060of semaglutide, making \u200bit \u200bthe \u200bsecond copycat \u200cversion of Danish drugmaker Novo Nordisk&#8217;s blockbuster \u200cdiabetes \u200bdrug \u200bOzempic \u200bauthorized in \u200cthe country.<\/p>\n<p class=\"yf-1fy9kyt\">(Reporting by \u200bIsmail \u200bShakil and \u200bRyan \u200cPatrick Jones; Editing \u200bby Caitlin \u200bWebber)<\/p>\n","protected":false},"excerpt":{"rendered":"OTTAWA, May 1 (Reuters) &#8211; The \u200cCanadian \u200chealth regulator said \u200bon Friday that it had \u200capproved Canada-based \u2060Apotex&#8217;s&hellip;\n","protected":false},"author":3,"featured_media":766714,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[205624,210,1060,9412,70645,67,132,68],"class_list":["post-766713","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-generic-version","tag-health","tag-medication","tag-novo-nordisk","tag-ryan-patrick-jones","tag-united-states","tag-unitedstates","tag-us"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116501384655664420","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/766713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=766713"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/766713\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/766714"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=766713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=766713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=766713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}